Interval Partners LP bought a new position in shares of Oracle Co. (NYSE:ORCL – Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 5,801 shares of the enterprise software provider’s stock, valued at approximately $819,000.
Other large investors have also made changes to their positions in the company. Westend Capital Management LLC acquired a new position in shares of Oracle during the first quarter valued at about $25,000. Fairway Wealth LLC bought a new stake in Oracle during the second quarter worth about $27,000. Frank Rimerman Advisors LLC bought a new stake in shares of Oracle during the fourth quarter valued at approximately $30,000. POM Investment Strategies LLC bought a new stake in shares of Oracle during the second quarter valued at approximately $30,000. Finally, Bbjs Financial Advisors LLC bought a new stake in shares of Oracle during the second quarter valued at approximately $35,000. Institutional investors and hedge funds own 42.44% of the company’s stock.
Oracle Price Performance
Shares of NYSE:ORCL opened at $165.80 on Wednesday. The firm has a 50 day moving average of $143.22 and a 200-day moving average of $132.84. The stock has a market capitalization of $459.43 billion, a PE ratio of 44.69, a PEG ratio of 3.05 and a beta of 1.01. The company has a current ratio of 0.72, a quick ratio of 0.72 and a debt-to-equity ratio of 6.68. Oracle Co. has a 12 month low of $99.26 and a 12 month high of $173.99.
Oracle Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Thursday, October 24th. Stockholders of record on Thursday, October 10th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 0.97%. The ex-dividend date is Thursday, October 10th. Oracle’s payout ratio is presently 43.13%.
Insider Activity at Oracle
In related news, insider Edward Screven sold 426,861 shares of Oracle stock in a transaction that occurred on Wednesday, July 10th. The shares were sold at an average price of $141.91, for a total transaction of $60,575,844.51. Following the sale, the insider now directly owns 2,626,764 shares of the company’s stock, valued at approximately $372,764,079.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other Oracle news, insider Edward Screven sold 426,861 shares of the business’s stock in a transaction that occurred on Wednesday, July 10th. The shares were sold at an average price of $141.91, for a total transaction of $60,575,844.51. Following the sale, the insider now directly owns 2,626,764 shares of the company’s stock, valued at approximately $372,764,079.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Chairman Lawrence Joseph Ellison sold 1,125,000 shares of the business’s stock in a transaction that occurred on Monday, July 15th. The stock was sold at an average price of $143.69, for a total transaction of $161,651,250.00. Following the sale, the chairman now directly owns 1,145,732,353 shares in the company, valued at $164,630,281,802.57. The disclosure for this sale can be found here. In the last three months, insiders have sold 1,573,181 shares of company stock valued at $225,338,245. 42.80% of the stock is owned by insiders.
Analysts Set New Price Targets
Several equities analysts recently weighed in on the stock. TD Cowen increased their price objective on shares of Oracle from $165.00 to $180.00 and gave the company a “buy” rating in a report on Tuesday, September 10th. Sanford C. Bernstein raised their target price on shares of Oracle from $159.00 to $171.00 and gave the company an “outperform” rating in a research report on Wednesday, June 12th. Melius Research raised shares of Oracle from a “hold” rating to a “buy” rating in a research report on Monday, September 16th. Citigroup lifted their price objective on shares of Oracle from $140.00 to $157.00 and gave the company a “neutral” rating in a research report on Wednesday, September 11th. Finally, Guggenheim lifted their price objective on shares of Oracle from $185.00 to $200.00 and gave the company a “buy” rating in a research report on Friday, September 13th. Ten analysts have rated the stock with a hold rating and twenty have assigned a buy rating to the company. According to data from MarketBeat.com, Oracle currently has an average rating of “Moderate Buy” and an average target price of $166.13.
Check Out Our Latest Research Report on ORCL
Oracle Company Profile
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Recommended Stories
- Five stocks we like better than Oracle
- What is a Stock Market Index and How Do You Use Them?
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Technology Stocks Explained: Here’s What to Know About Tech
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Co. (NYSE:ORCL – Free Report).
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.